CAS: 98224-03-4 - Eltoprazine
Formula:C12H17ClN2O2
InChI:InChI=1S/C12H16N2O2/c1-2-10(14-6-4-13-5-7-14)12-11(3-1)15-8-9-16-12/h1-3,13H,4-9H2
InChI key:InChIKey=WVLHGCRWEHCIOT-UHFFFAOYSA-N
SMILES:O1C2=CC=CC(=C2OCC1)N3CCNCC3
- Synonyms:
- 1,4-Benzodioxin, piperazine deriv.
- 1-(1,4-Benzodioxan-5-yl)piperazine
- 1-(2,3-Dihydro-1,4-Benzodioxin-5-Yl)Piperazine Hydrochloride
- 1-(2,3-Dihydro-1,4-benzodioxan-5-yl)piperazine
- 1-(2,3-Dihydro-1,4-benzodioxin-5-yl)piperazine
- 1-(2,3-Dihydrobenzo[b][1,4]dioxin-5-yl)piperazine
- 4-(2,3-Dihydro-1,4-benzodioxin-5-yl)-1-piperazine
- 4-(2,3-Dihydrobenzo[1,4]dioxin-5-yl)piperazine
- Eltoprazina
- Eltoprazina [Spanish]
- See more synonyms
- Eltoprazine [INN]
- Eltoprazinum
- Eltoprazinum [Latin]
- N-(2,3-Dihydrobenzo[1,4]dioxin-5-yl)piperazine
- Piperazine, 1-(2,3-dihydro-1,4-benzodioxin-5-yl)-
- Unii-510M006Ko6
Eltoprazine
CAS:98224-03-4
Eltoprazine(DU28853) is a serenic or antiaggressive agent which as an agonist at the 5-HT1A and …
Formula:
C12H16N2O2
Color and Shape:
Solid
Molecular weight:
220.27
Ref: TM-T38145
25mg | 1,386.00 € | ||
50mg | 1,805.00 € | ||
100mg | 2,279.00 € |
Estimated delivery in United States, on Tuesday 3 Dec 2024
Eltoprazine-d4 Hydrochloride
Controlled ProductFormula:
C12D4H12N2O2·HCl
Color and Shape:
Neat
Molecular weight:
260.753
Ref: TR-E507502
25mg | 3,571.00 € |
Estimated delivery in United States, on Tuesday 7 Jan 2025
Eltoprazine
Controlled ProductCAS:98224-03-4
Formula:
C12H16N2O2
Color and Shape:
Neat
Molecular weight:
220.268
Ref: TR-E507503
100mg | 1,048.00 € |
Estimated delivery in United States, on Tuesday 7 Jan 2025
1-(2,3-Dihydrobenzo[b][1,4]dioxin-5-yl)piperazine hydrochloride
Controlled ProductCAS:98224-03-4
1-(2,3-Dihydrobenzo[b][1,4]dioxin-5-yl)piperazine hydrochloride (DBDFP) is a dopamine receptor agonist and 5-HT2 receptor antagonist that has been …
Formula:
C12H17ClN2O2
Purity:
Min. 95%
Molecular weight:
256.73 g/mol
Ref: 3D-FD156233
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire |
Estimated delivery in United States, on Tuesday 7 Jan 2025